High-sensitivity C-reactive protein and parameters of left ventricular dysfunction

Journal of Cardiac Failure

Volumn 12, Issue 1, 2006, Pages 61-65

  Shah, Sanjiv J ^a   Marcus, Gregory M ^a   Gerber, Ivor L ^a   McKeown, Barry H ^a   Vessey, Joshua C ^a   Jordan, Mark V ^a   Huddleston, Michele ^a   Foster, Elyse ^a   Chatterjee, Kanu ^a   Michaels, Andrew D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C reactive protein; Cardiac catheterization; Ejection fraction; Heart failure; Inflammation; Left ventricular end diastolic pressure; Natriuretic peptides

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIASTOLE; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 33144467116     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2005.08.003     Document Type: Article

References (35)

1. A. Matsumori Anti-inflammatory therapy for heart failure Curr Opin Pharmacol 4 2004 171 176
2. J.M. Backes, P.A. Howard, and P.M. Moriarty Role of C-reactive protein in cardiovascular disease Ann Pharmacother 38 2004 110 118
3. K. Werdan The activated immune system in congestive heart failure - from dropsy to the cytokine paradigm J Intern Med 243 1998 87 92
4. I.C. Steele, A.M. Nugent, S. Maguire, M. Hoper, G. Campbell, and M.I. Halliday Cytokine profile in chronic cardiac failure Eur J Clin Invest 26 1996 1018 1022
5. R. Ferrari, T. Bachetti, R. Confortini, C. Opasich, O. Febo, and A. Corti Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure Circulation 92 1995 1479 1486
6. T.B. Harris, L. Ferrucci, R.P. Tracy, M.C. Corti, S. Wacholder, and W.H. Ettinger Jr. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly Am J Med 106 1999 506 512
7. G.A. MacGowan, D.L. Mann, R.L. Kormos, A.M. Feldman, and S. Murali Circulating interleukin-6 in severe heart failure Am J Cardiol 79 1997 1128 1131
8. Y. Sato, Y. Takatsu, K. Kataoka, T. Yamada, R. Taniguchi, and S. Sasayama Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation Clin Cardiol 22 1999 811 813
9. J.L. Alonso-Martinez, B. Llorente-Diez, M. Echegaray-Agara, F. Olaz-Preciado, M. Urbieta-Echezarreta, and C. Gonzalez-Arencibia C-reactive protein as a predictor of improvement and readmission in heart failure Eur J Heart Fail 4 2002 331 336
10. J.T. Beranek C-reactive protein and complement in myocardial infarction and postinfarction heart failure Eur Heart J 18 1997 1834 1836
11. G. Berton, R. Cordiano, R. Palmieri, S. Pianca, V. Pagliara, and P. Palatini C-reactive protein in acute myocardial infarction: association with heart failure Am Heart J 145 2003 1094 1101
12. R.S. Vasan, L.M. Sullivan, R. Roubenoff, C.A. Dinarello, T. Harris, and E.J. Benjamin Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study Circulation 107 2003 1486 1491
13. J.S. Gottdiener, A.M. Arnold, G.P. Aurigemma, J.F. Polak, R.P. Tracy, and D.W. Kitzman Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study J Am Coll Cardiol 35 2000 1628 1637
14. M. Pye, A.P. Rae, and S.M. Cobbe Study of serum C-reactive protein concentration in cardiac failure Br Heart J 63 1990 228 230
15. K. Kaneko, T. Kanda, Y. Yamauchi, A. Hasegawa, T. Iwasaki, and M. Arai C-Reactive protein in dilated cardiomyopathy Cardiology 91 1999 215 219
16. W.P. Huang, W.H. Yin, H.L. Jen, M.C. Chiang, A.N. Feng, and M.S. Young C-reactive protein levels in chronic congestive heart failure Acta Cardiol Sin 20 2004 7 14
17. W.H. Yin, J.W. Chen, H.L. Jen, M.C. Chiang, W.P. Huang, and A.N. Feng Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure Am Heart J 147 2004 931 938
18. M. Cesari, B.W. Penninx, A.B. Newman, S.B. Kritchevsky, B.J. Nicklas, and K. Sutton-Tyrrell Inflammatory markers and onset of cardiovascular events: results from the Health ABC study Circulation 108 2003 2317 2322
19. J.A. Chirinos, J.P. Zambrano, S. Chakko, A. Schob, A. Veerani, and G.O. Perez Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy Am J Cardiol 95 2005 88 90
20. K.K. Ho, J.L. Pinsky, W.B. Kannel, and D. Levy The epidemiology of heart failure: the Framingham Study J Am Coll Cardiol 22 Suppl A 1993 6A 13A
21. E.T. Yeh, and J.T. Willerson Coming of age of C-reactive protein: using inflammation markers in cardiology Circulation 107 2003 370 371
22. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
23. T.A. Pearson, G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon 3rd, and M. Criqui Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
24. B. Shine, F.C. de Beer, and M.B. Pepys Solid phase radioimmunoassays for human C-reactive protein Clin Chim Acta 117 1981 13 23
25. M.B. Pepys, and G.M. Hirschfield C-reactive protein: a critical update J Clin Invest 111 2003 1805 1812
26. G. Marcus, I.L. Gerber, B. McKeown, J. Vessey, M.V. Jordan, and M. Huddleston Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function JAMA 293 2005 2238 2244
27. N.B. Schiller, P.M. Shah, M. Crawford, A. DeMaria, R. Devereux, and H. Feigenbaum Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
28. P.M. Mottram, and T.H. Marwick Assessment of diastolic function: what the general cardiologist needs to know Heart 2005 681 695
29. G. Targher, L. Bertolini, G. Zoppini, L. Zenari, and G. Falezza Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in type 1 diabetic patients without clinically manifest macroangiopathy Diabet Med 22 2005 999 1004
30. T. McLaughlin, F. Abbasi, C. Lamendola, L. Liang, G. Reaven, and P. Schaaf Differentiation between obesity and insulin resistance in the association with C-reactive protein Circulation 106 2002 2908 2912
31. Y. Lin, M.W. Rajala, J.P. Berger, D.E. Moller, N. Barzilai, and P.E. Scherer Hyperglycemia induced production of acute phase reactants in adipose tissue J Biol Chem 276 2001 42077 42083
32. A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327 334
33. G.C. Fonarow The treatment targets in acute decompensated heart failure Rev Cardiovasc Med 2 Suppl 2 2001 S7 S12
34. K. Yamauchi-Takihara, Y. Ihara, A. Ogata, K. Yoshizaki, J. Azuma, and T. Kishimoto Hypoxic stress induces cardiac myocyte-derived interleukin-6 Circulation 91 1995 1520 1524
35. D.J. Clark, M.W. Cleman, S.E. Pfau, S.A. Rollins, T.M. Ramahi, and C. Mayer Serum complement activation in congestive heart failure Am Heart J 141 2001 684 690